BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6123322)

  • 1. The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
    Sivelle PC; Underwood AH; Jelly JA
    Biochem Pharmacol; 1982 Mar; 31(5):677-84. PubMed ID: 6123322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo comparisons of antiandrogenic potencies of two histamine H2-receptor antagonists, cimetidine and etintidine--HCl.
    Foldesy RG; Vanderhoof MM; Hahn DW
    Proc Soc Exp Biol Med; 1985 Jun; 179(2):206-10. PubMed ID: 2859600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat.
    Neubauer BL; Goode RL; Best KL; Hirsch KS; Lin TM; Pioch RP; Probst KS; Tinsley FC; Shaar CJ
    Toxicol Appl Pharmacol; 1990 Feb; 102(2):219-32. PubMed ID: 1967857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cimetidine is an antiandrogen in the rat.
    Winters SJ; Banks JL; Loriaux DL
    Gastroenterology; 1979 Mar; 76(3):504-8. PubMed ID: 428705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
    Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
    Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifentidine: evaluation of antiandrogen effects and kidney function studies.
    Francalanza G; Franco C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):456-8. PubMed ID: 2859037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors.
    Funder JW; Mercer JE
    J Clin Endocrinol Metab; 1979 Feb; 48(2):189-91. PubMed ID: 429472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on the antiandrogenic effects of cimetidine versus cyproterone acetate in rats.
    Baba S; Paul HJ; Pollow K; Janetschek G; Jacobi GH
    Prostate; 1981; 2(2):163-74. PubMed ID: 6458024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.
    Ghanadian R; Smith CB; Williams G; Chisholm GD
    Br J Urol; 1977; 49(7):695-700. PubMed ID: 74269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marihuana inhibits dihydrotestosterone binding to the androgen receptor.
    Purohit V; Ahluwahlia BS; Vigersky RA
    Endocrinology; 1980 Sep; 107(3):848-50. PubMed ID: 6249575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.
    Saartok T; Dahlberg E; Gustafsson JA
    Endocrinology; 1984 Jun; 114(6):2100-6. PubMed ID: 6539197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An interaction of histamine H2-receptor antagonists with the noradrenergic system in rat brain.
    Nowak JZ; Pilc A; Maśliński C
    Eur J Pharmacol; 1978 Sep; 51(1):71-5. PubMed ID: 29763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors.
    Eil C; Edelson SK
    J Clin Endocrinol Metab; 1984 Jul; 59(1):51-5. PubMed ID: 6725525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-androgen TSAA-291. VI. Effects of the anti-androgen TSAA-291 and its related compounds on the in vitro formation of 5 alpha-DHT-receptor complex in the cytosol of rat ventral prostates.
    Sudo K; Yoshida K; Nakayama R
    Acta Endocrinol Suppl (Copenh); 1979; 229():82-99. PubMed ID: 294109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of H2-receptor antagonists on prolactin secretion: specificity and mediation of the response.
    Knigge U; Matzen S; Warberg J
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):461-8. PubMed ID: 2888250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histamine, H1- and H2-receptor antagonists on the activity of serotonergic neurons in the dorsal raphe nucleus.
    Lakoski JM; Aghajanian GK
    J Pharmacol Exp Ther; 1983 Nov; 227(2):517-23. PubMed ID: 6138428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ketoconazole related imidazole drugs and antiandrogens on [3H] R 1881 binding to the prostatic androgen receptor and [3H]5 alpha-dihydrotestosterone and [3H]cortisol binding to plasma proteins.
    Ayub M; Levell MJ
    J Steroid Biochem; 1989 Aug; 33(2):251-5. PubMed ID: 2788775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.